A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis
Efficacy and Safety of Double-pigtail Plastic Versus Lumen-apposing Metal Stents for Transmural Drainage of Walled-off Necrosis
1 other identifier
interventional
50
1 country
1
Brief Summary
Walled-off necrosis (WON) is defined as an encapsulated collection of solid and liquid necrotic material that is usually formed 4 weeks after an episode of acute necrotizing pancreatitis. As the advances in endoscopic techniques and accessories, Endoscopic ultrasound (EUS)-guided transluminal drainage has evolved to become the treatment of choice for symptomatic pancreatic walled-off necrosis (WON). This article aims to compare the efficacy and safety of a double mushroom head metal stent and a double pigtail plastic stent in the treatment of encapsulated necrosis of the pancreas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFebruary 21, 2023
February 1, 2023
1.7 years
April 30, 2021
February 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical success (clinical improvement and resolution of WON)
compare rates of WON resolution in patients with LAMS and DPPS for treatment of walled-off necrosis
two months
Secondary Outcomes (1)
Adverse Events
two months
Study Arms (2)
LAMS group
EXPERIMENTALplace LAMS under endoscopic ultrasound. Direct endoscopic necrosectomy(DEN) was performed through the LAMS with a forward viewing gastroscope if necessary
DPPS group
ACTIVE COMPARATORPlace DPPS under endoscopic ultrasound. When required, DEN was performed once the cystogastrostomy/duodenostomy tract had matured. This was done by first removing the stents followed by dilation of the tract with a radial expansion balloon and insertion of a forward viewing gastroscope through the tract for DEN
Interventions
All patients were implanted with stents(DPPS or LAMS)under the EUS
Eligibility Criteria
You may qualify if:
- Obtention of a written informed consent
- According to Revised Atlanta Classification, abdominal CT/MRI and EUS were diagnosed as WON
- The diameter of WON ≥6cm
- Patient capable of fill in the quality of life questionnaire
- The distance between the EUS-probe and WON was \< 1 cm.
You may not qualify if:
- No written informed consent
- pancreatic cystic tumor, pancreatic cancer and other benign and malignant tumors
- pancreatic pseudocyst
- WON too far from the stomach and duodenum to perform endoscopic drainage
- Serious abnormalities in liver and kidney function and coagulation function
- Pregnant, parturient or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jianfeng Yang
Hangzhou, Zhejiang, 310006, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Xiaofeng Zhang, M.S
First People's Hospital of Hangzhou
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy irector
Study Record Dates
First Submitted
April 30, 2021
First Posted
May 6, 2021
Study Start
May 1, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
February 21, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share